Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
59,993,887
-
Share change
-
+2,072,599
-
Total reported value
-
$943,651,739
-
Put/Call ratio
-
575%
-
Price per share
-
$15.73
-
Number of holders
-
176
-
Value change
-
+$32,281,648
-
Number of buys
-
91
-
Number of sells
-
65
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q1 2024
As of 31 Mar 2024,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,993,887 shares.
The largest 10 holders included
BlackRock Inc., ARMISTICE CAPITAL, LLC, Redmile Group, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, and Polar Capital Holdings Plc.
This page lists
176
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.